Unlike in the rest of the country, where intestinal ultrasound rarely is used in the clinic, in New York City, gastroenterologists at Mount Sinai Hospital have made IUS findings the “the fifth vital sign” for inflammatory bowel disease patient care, particularly to monitor disease. Now, new research from the institution and other centers is showing that the tool can identify patients with endoscopic recurrence and possibly predict disease outcomes and treatment response.
Trending
- Listening to Patients: The Most Radical Innovation in GI?(A Candid Conversation with Dr. Neil Parikh)
- Roche launches fibrosis blood test for gauging liver disease severity (Fierce Healthcare)
- Updated Guidelines Aim to Improve GERD Diagnosis and Treatment (AJMC)
- The All New WHOOP: The World’s Most Powerful Health Wearable (Forbes)
- Priority Health launches new digestive health solution in partnership with Ayble Health (Priority Health)
- Weighing the Environmental Impact of Colorectal Cancer Screening Methods (ReachMD)
- WeightWatchers Files for Bankruptcy Amid Wave of New Weight-Loss Methods (The New York Times)
- FDA Announces Completion of First AI-Assisted Scientific Review Pilot and Aggressive Agency-Wide AI Rollout Timeline (FDA)